282 related articles for article (PubMed ID: 26022889)
21. Indomethacin-Kollidon VA64 Extrudates: A Mechanistic Study of pH-Dependent Controlled Release.
Tres F; Treacher K; Booth J; Hughes LP; Wren SA; Aylott JW; Burley JC
Mol Pharm; 2016 Mar; 13(3):1166-75. PubMed ID: 26845251
[TBL] [Abstract][Full Text] [Related]
22. Physical properties and in vivo bioavailability in human volunteers of isradipine using controlled release matrix tablet containing self-emulsifying solid dispersion.
Tran PH; Tran TT; Piao ZZ; Vo TV; Park JB; Lim J; Oh KT; Rhee YS; Lee BJ
Int J Pharm; 2013 Jun; 450(1-2):79-86. PubMed ID: 23612354
[TBL] [Abstract][Full Text] [Related]
23. Can dosage form-dependent food effects be predicted using biorelevant dissolution tests? Case example extended release nifedipine.
Andreas CJ; Tomaszewska I; Muenster U; van der Mey D; Mueck W; Dressman JB
Eur J Pharm Biopharm; 2016 Aug; 105():193-202. PubMed ID: 27322002
[TBL] [Abstract][Full Text] [Related]
24. Enhanced Dissolution of a Porous Carrier-Containing Ternary Amorphous Solid Dispersion System Prepared by a Hot Melt Method.
Hanada M; Jermain SV; Williams RO
J Pharm Sci; 2018 Jan; 107(1):362-371. PubMed ID: 28989021
[TBL] [Abstract][Full Text] [Related]
25. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system.
Tiwari SB; Murthy TK; Pai MR; Mehta PR; Chowdary PB
AAPS PharmSciTech; 2003; 4(3):E31. PubMed ID: 14621963
[TBL] [Abstract][Full Text] [Related]
26. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
Sun DD; Ju TC; Lee PI
Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
[TBL] [Abstract][Full Text] [Related]
27. [Modern polymers in matrix tablets technology].
Zimmer Ł; Kasperek R; Poleszak E
Polim Med; 2014; 44(3):189-96. PubMed ID: 25739125
[TBL] [Abstract][Full Text] [Related]
28. A novel approach in distinguishing between role of hydrodynamics and mechanical stresses similar to contraction forces of GI tract on drug release from modified release dosage forms.
Takieddin M; Fassihi R
AAPS PharmSciTech; 2015 Apr; 16(2):278-83. PubMed ID: 25273030
[TBL] [Abstract][Full Text] [Related]
29. Synergetic Role of Hypromellose and Methacrylic Acid Copolymer in the Dissolution Improvement of Amorphous Solid Dispersions.
Ohyagi N; Ueda K; Higashi K; Yamamoto K; Kawakami K; Moribe K
J Pharm Sci; 2017 Apr; 106(4):1042-1050. PubMed ID: 27988162
[TBL] [Abstract][Full Text] [Related]
30. An integrated system for dissolution studies and magnetic resonance imaging of controlled release, polymer-based dosage forms-a tool for quantitative assessment of hydrogel formation processes.
Kulinowski P; Dorozyński P; Jachowicz R; Weglarz WP
J Pharm Biomed Anal; 2008 Nov; 48(3):685-93. PubMed ID: 18715732
[TBL] [Abstract][Full Text] [Related]
31. Effect of Extent of Supersaturation on the Evolution of Kinetic Solubility Profiles.
Han YR; Lee PI
Mol Pharm; 2017 Jan; 14(1):206-220. PubMed ID: 28043130
[TBL] [Abstract][Full Text] [Related]
32. Study the effect of formulation variables on drug release from hydrophilic matrix tablets of milnacipran and prediction of in-vivo plasma profile.
Singhvi G; Shah A; Yadav N; Saha RN
Pharm Dev Technol; 2014 Sep; 19(6):708-16. PubMed ID: 23931031
[TBL] [Abstract][Full Text] [Related]
33. Effects of Dissolution Medium pH and Simulated Gastrointestinal Contraction on Drug Release From Nifedipine Extended-Release Tablets.
Gao Z; Ngo C; Ye W; Rodriguez JD; Keire D; Sun D; Wen H; Jiang W
J Pharm Sci; 2019 Mar; 108(3):1189-1194. PubMed ID: 30343136
[TBL] [Abstract][Full Text] [Related]
34. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
[TBL] [Abstract][Full Text] [Related]
35. Dissolution-modulating mechanism of pH modifiers in solid dispersion containing weakly acidic or basic drugs with poor water solubility.
Tran PH; Tran TT; Lee KH; Kim DJ; Lee BJ
Expert Opin Drug Deliv; 2010 May; 7(5):647-61. PubMed ID: 20205605
[TBL] [Abstract][Full Text] [Related]
36. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
[TBL] [Abstract][Full Text] [Related]
37. Enhanced release of poorly water-soluble drugs from synergy between mesoporous magnesium carbonate and polymers.
Yang J; Alvebratt C; Zhang P; Zardán Gómez de la Torre T; Strømme M; Bergström CAS; Welch K
Int J Pharm; 2017 Jun; 525(1):183-190. PubMed ID: 28396244
[TBL] [Abstract][Full Text] [Related]
38. Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: II. Influencing variables, stability and pharmacokinetics in dogs.
Wu B; Deng D; Lu Y; Wu W
Eur J Pharm Biopharm; 2008 May; 69(1):294-302. PubMed ID: 17988844
[TBL] [Abstract][Full Text] [Related]
39. Counter-intuitive enhancement in the dissolution of indomethacin with the incorporation of cohesive poorly water-soluble inorganic salt additives.
Tay T; Allahham A; Morton DA; Stewart PJ
Eur J Pharm Biopharm; 2011 Nov; 79(3):674-82. PubMed ID: 21703348
[TBL] [Abstract][Full Text] [Related]
40. Release of poorly soluble drugs from HPMC tablets studied by FTIR imaging and flow-through dissolution tests.
van der Weerd J; Kazarian SG
J Pharm Sci; 2005 Sep; 94(9):2096-109. PubMed ID: 16052556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
